Ripple Therapeutics
PrivateLast Round
Grant
Apr 27, 2022
Total Funding Raised
$12.38M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Ripple Therapeutics operates in Healthcare & Life Sciences and is based in Toronto, Ontario. Its latest recorded funding round was a Grant round in April 2022.
Ripple Therapeutics is a clinical-stage ophthalmic therapeutics company developing a drug delivery system for controllable, sustained drug delivery without the use of polymers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ripple Therapeutics Comparables
Compare Ripple Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| PolyActiva | 84% | |
| EyeD Pharma | 84% | |
| EyePoint, Inc. | 80% |
For institutional investors. Book with your work email.
Ripple Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Apr 27, 2022 | ||||
| Grant | Feb 5, 2021 | ||||
| Series A | Dec 10, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Ripple Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BDC Capital | Series A |
| National Research Council Canada Industrial Research Assistance Program | Grant |
| Natural Sciences and Engineering Research Council of Canada | Grant |
| Théa Open Innovation | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors increased 39% MoM.
- Jun 23, 2026
Monthly visitors increased 39% MoM.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- attends_eventSep 8, 2026
Ripple Therapeutics Corporation presents at the OBIO(R) Investment Summit.
- receives_awardSep 8, 2026
Ripple Therapeutics Corporation receives BIOTECanada’s 2026 Gold Leaf Award for Promising Biotech Company of the Year, recognizing its innovative sustained drug delivery platform, clinical momentum, and key partnerships.
- receives_awardSep 1, 2026
BIOTECanada recognizes Ripple Therapeutics Corporation as Promising Biotech Company of the Year at the Gold Leaf Awards Ceremony in Canada on Sep 22nd '26.
- recognized_asSep 1, 2026
BIOTECanada names Ripple Therapeutics Corporation a 2026 Gold Leaf Award honoree as Promising Biotech Company of the Year, with recipients selected by an independent committee and set to receive recognition at the Gold Leaf Awards Ceremony in Canada on Sep 22nd '26.
For institutional investors. Book with your work email.
Ripple Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Ripple Therapeutics's valuation, stock price, and market status.
Is Ripple Therapeutics a public or private company?
Ripple Therapeutics is a private company.
What is the current stock price of Ripple Therapeutics?
Ripple Therapeutics is a private company, so its shares have no public market price. Caplight tracks Ripple Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Ripple Therapeutics worth (valuation)?
Valuation information for Ripple Therapeutics is not publicly available.
Can I buy Ripple Therapeutics stock?
Ripple Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Ripple Therapeutics's last funding round?
Ripple Therapeutics's most recent funding round was Grant on April 27, 2022.
Who are the main investors in Ripple Therapeutics?
Key investors in Ripple Therapeutics include Théa Open Innovation.
Will Ripple Therapeutics IPO soon?
No public IPO plans have been announced for Ripple Therapeutics.
How can I track Ripple Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Ripple Therapeutics's shares on secondary markets.